• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There are few data on how long-term exposure may affect a pregnant fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and take ADHD medication need to evaluate the benefits of using it versus the risks for the foetus. Doctors don't have the information needed to give clear guidelines but they can provide information on risks and benefits that assist pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers conducted a large population-based case control study to examine the prevalence of major structural defects in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists, clinical geneticists and other experts reviewed the cases in order to ensure that the classification was accurate and to eliminate any bias.

The study of the researchers was not without limitations. Most important, they were unable to separate the effects of the medication from those of the disorder at hand. That limitation makes it difficult to determine whether the small associations observed in the exposed groups result from medication use or comorbidities that cause confusion. Researchers also did not study long-term outcomes for offspring.

The study did show that infants whose mothers had taken ADHD medication during pregnancy were at slightly more risk of being admitted to the neonatal intensive care unit (NICU) than those whose mothers had not taken any medication or stopped their medications before or during pregnancy. This was due to central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medication was used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the small risk of using ADHD medication during pregnancies in the early stages could be offset by the greater benefits to both baby and mother of continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, when possible, help them develop strategies to improve their coping abilities that may minimize the effects of her disorder on her daily functioning and relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are usually taken without clear and authoritative evidence. Instead, doctors must weigh their own knowledge and experience, as well as the experiences of other physicians and the research that has been conducted on the subject.

Particularly, the issue of potential risks to the baby can be tricky. A lot of studies on this topic are based on observational data instead of controlled research and their conclusions are often contradictory. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that lead to abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations, by examining both the data from deceased and live births.

The conclusion: While some studies have found a positive association between ADHD medications and the risk of certain birth defects, other studies have found no such relationship and the majority of studies show a neutral or even slightly negative impact. In each case it is imperative to conduct a thorough analysis of the risks and benefits must be performed.

It can be difficult, if not impossible for women with ADHD to stop taking their medication. In an article recently published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping what adhd medications are there uk medication during pregnancy can lead to increased depression, feelings of loneliness, and family conflict for these patients. A decrease in medication could affect the ability to safely drive and to perform work-related tasks which are crucial aspects of daily life for those with ADHD.

She suggests that women who aren't sure whether to continue taking the medication or stop due to pregnancy, educate their family members, colleagues, and acquaintances about the condition, the effects on daily functioning, and the benefits of continuing the current treatment. It can also help women feel confident about her decision. It is also worth noting that some medications are able to pass through the placenta therefore, if a patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the medication could be transferred to the child.

Birth Defects and Risk of

As the use and misuse of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (Adhd medication Pregnancy), increases as does the concern about the potential effects of these drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, first-trimester ADHD medication use was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The authors of the study found no connection between the use of early medications and congenital abnormalities such as facial clefting or club foot. The results are consistent with previous studies revealing the presence of a small, but significant increase in the risk of heart malformations in women who started taking ADHD medications before pregnancy. This risk increased during the latter part of pregnancy, when a lot of women began to stop taking their medication.

Women who were taking ADHD medication during the first trimester were more likely to require a caesarean birth and also have a low Apgar after delivery, and had a baby that required help breathing when they were born. However the researchers of the study were unable to eliminate bias due to selection by limiting the study to women who did not have other medical issues that could have contributed to these findings.

The researchers hope their research will serve to inform the clinical decisions of doctors who encounter pregnant women. The researchers advise that, while discussing the risks and benefits are important, the choice on whether to continue or stop medication should be made in light of the severity of each woman's adhd treatment medication symptoms and the needs of the woman.

The authors also warn that, while stopping the medication is an alternative, it is not a recommended practice because of the high incidence of depression and other mental health issues in women who are pregnant or postpartum. Additionally, the research suggests that women who choose to stop their medications are more likely to experience difficulties getting used to life without them following the birth of their baby.

Nursing

The responsibilities of being a new mom can be overwhelming. Women with ADHD who have to deal with their symptoms while attending doctor appointments and getting ready for the arrival of their child and adapting to new routines in the home may face a lot of challenges. This is why many women choose to continue taking their ADHD medications throughout pregnancy.

The risk for nursing infant is low because the majority of stimulant medication is absorbed through breast milk at low levels. The amount of exposure to medications will vary based on the dosage the medication is administered, its frequency and the time of the day. In addition, various drugs enter the infant's system through the gastrointestinal tract or through breast milk. The effect on the health of a newborn isn't completely understood.

Due to the absence of evidence, some doctors may be inclined to discontinue stimulant medication during a woman's pregnancy. This is a difficult decision for the patient, who must balance the benefits of continuing her medication against the potential dangers to the embryo. Until more information becomes available, GPs can ask pregnant patients if they have any history of ADHD or if they intend to take medication during the perinatal period.

Numerous studies have proven that women can continue taking their ADHD medication in a safe manner during pregnancy and while breast-feeding. This has led to many patients are choosing to do so and in consultation with their doctor they have found that the benefits of keeping their current medication far exceed any risk.

Women with ADHD who plan to breastfeed should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also be informed about treatment options and build the coping mechanisms. This should be a multidisciplinary approach with the GPs, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan genetic testing for adhd medications the mother and child, monitoring of signs of deterioration and, if necessary, adjustments to the medication regime.